Sun Pharmaceutical Industries Ltd on Monday said it has received a tax demand of over Rs 1.11 crore from authorities over disallowed input tax credit.
The company has received an order from the Joint Commissioner, CGST and Central Excise, passed under the GST Act, raising a demand of Rs 1,11,60,156, imposing a penalty of Rs 11,16,016 and interest as applicable, Sun Pharmaceutical Industries said in a regulatory filing.
The reason for the order is disallowed input tax credit on account of inadmissible transitional credit, it added.
ADVERTISEMENT
"There is no material impact on financial, operation or other activities of the company," the filing said.
Add us to your Preferences
Set as your preferred source on Google
ADVERTISEMENT
RECOMMENDED FOR YOU
GST Rate Cuts: Salon, Gym, Yoga Centre Services To Get Cheaper
Sep 04, 2025
Why Insurance Players Are Also Batting For A 5% GST Slab Instead Of Full Exemption
Aug 21, 2025
GST Relief Could Cut Insurance Premiums By Up To 15%, Depending On Credit Claims
Aug 21, 2025
Profit Explains: Why GST Cuts On Insurance Without Input Tax Credit Will Not Bring Down Premiums
Aug 19, 2025
POPULAR
1
Meta, Microsoft Urge H-1B Visa Holders To Return To US Quickly, Not Leave For 'Foreseeable Future'
2
Trump’s $100,000 H-1B Fee Will Choke US Innovation And Turbocharge India, Says Amitabh Kant
3
GST 2.0 Impact: Royal Enfield To KTM — Here's How Two-Wheeler Rates Will Change From Sept 22
4
Atlanta Electricals IPO: Price Band, Financials, Key Dates, And More — All You Need To Know
5